Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ninot

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Life Support Systems : the Journal of the European Society for Artificial Organs|January 1, 1985
Microporous polyurethane (Mitrathane) in cardiovascular surgeryC A Mestres, J L Pomar, S Ninot, et al.
Future Microbiology|June 30, 2015
Enterococcal endocarditis revisitedJ M Pericás, Y Zboromyrska, C Cervera, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2017
Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditisJ M Pericàs, C García-de-la-Mària, M Brunet, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2010
Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidisC García-de-la-Mària, F Marco, Y Armero, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 22, 2014
Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxoneJ M Pericas, C Cervera, A del Rio, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2015
Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureusA del Río, C García-de-la-Mària, J M Entenza, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Life Support Systems : the Journal of the European Society for Artificial Organs|January 1, 1985
Microporous polyurethane (Mitrathane) in cardiovascular surgeryC A Mestres, J L Pomar, S Ninot, et al.
Future Microbiology|June 30, 2015
Enterococcal endocarditis revisitedJ M Pericás, Y Zboromyrska, C Cervera, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2017
Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditisJ M Pericàs, C García-de-la-Mària, M Brunet, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2010
Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidisC García-de-la-Mària, F Marco, Y Armero, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 22, 2014
Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxoneJ M Pericas, C Cervera, A del Rio, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2015
Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureusA del Río, C García-de-la-Mària, J M Entenza, et al.
Pageof 3